Echocardiography-based Motion Integration and Management for Substrate Characterization and STAR Therapy in Ventricular Tachycardias
- Disease/Condition
- Ventricular Arrythmia
- Study type
- Observational
- Primary sponsor
- University of Luebeck
- Location
- Luebeck, Germany
- Phase
- N/A
- Start date
- Aug 01, 2023
- End date
- Jun 01, 2024
- Enrollment
- 20 participants
Feasibility of algorithm training to achieve improved arrhythmogenic substrate characterization,Feasibility of algorithm training to improve the planning target volume definition for stereotactic arrhythmia radioablation therapy
Prospective, observational, single center, pilot study to analyze the feasibility of motion
 and structural data integration in patients with ventricular arrhythmia by means of
 artificial intelligence for improved arrhythmogenic substrate characterization and motion
 management during stereotactic arrhythmia radioablation.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT05964660
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT05964660 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Luebeck and is currently Not yet recruiting. The study focuses on Ventricular Arrythmia. Target enrollment is 20 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.